Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1956 Nov;35(11):1183–1190. doi: 10.1172/JCI103372

STUDIES ON THE CLOT-PROMOTING ACTIVITY OF GLASS

Eleazar Shafrir 1, Andre de Vries 1,1
PMCID: PMC441694  PMID: 13376710

Full text

PDF
1183

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BIGGS R., DOUGLAS A. S., MACFARLANE R. G. The initial stages of blood coagulation. J Physiol. 1953 Dec 29;122(3):538–553. doi: 10.1113/jphysiol.1953.sp005019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conley C. L., Hartmann R. C., Morse W. I., 2nd THE CLOTTING BEHAVIOR OF HUMAN "PLATELET-FREE" PLASMA: EVIDENCE FOR THE EXISTENCE OF A "PLASMA THROMBOPLASTIN". J Clin Invest. 1949 Mar;28(2):340–352. doi: 10.1172/JCI102077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DE VRIES A., HERZ N., HEIMAN-HOLLANDER E. Observations on prothrombin consumption during clotting of normal blood in glass. Acta Med Scand. 1950;138(3):219–224. doi: 10.1111/j.0954-6820.1950.tb10116.x. [DOI] [PubMed] [Google Scholar]
  4. DE VRIES A., SHAFRIR E. Méthode d'évaluation de l'activité thromboplastique du plasma; applications cliniques et physiologiques. Rev Hematol. 1952;7(4):481–494. [PubMed] [Google Scholar]
  5. DICK F. W., JACKSON D. P., CONLEY C. L. Surface as a quantitative factor in prothrombin utilization. J Clin Invest. 1954 Nov;33(11):1423–1433. doi: 10.1172/JCI103020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DUCKERT F., FLUCKIGER P., MATTER M., KOLLER F. Clotting factor X; physiologic and physico-chemical properties. Proc Soc Exp Biol Med. 1955 Oct;90(1):17–22. doi: 10.3181/00379727-90-21927. [DOI] [PubMed] [Google Scholar]
  7. FIALA S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch Int Physiol. 1951 Feb;58(4):386–411. doi: 10.3109/13813455109144971. [DOI] [PubMed] [Google Scholar]
  8. HARTMANN R. C., CONLEY C. L. Studies on the initiation of blood coagulation, III. The clotting properties of canine platelet-free plasma. J Clin Invest. 1952 Jul;31(7):685–691. doi: 10.1172/JCI102650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JURGENS J. Factor VII-inhibitor; a new physiological serum accelerator inactivation principle. Acta Haematol. 1955 Jul;14(1):57–62. doi: 10.1159/000204971. [DOI] [PubMed] [Google Scholar]
  10. LANCHANTIN G. F., WARE A. G. Identification of a thromboplastin inhibitor in serum and in plasma. J Clin Invest. 1953 Apr;32(4):381–389. doi: 10.1172/JCI102749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. NEVO A., DE VRIES A., KATCHALSKY A. Interaction of basic polyamino acids with the red blood cell. I. Combination of polylysine with single cells. Biochim Biophys Acta. 1955 Aug;17(4):536–547. doi: 10.1016/0006-3002(55)90416-9. [DOI] [PubMed] [Google Scholar]
  12. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  13. QUICK A. J., EPSTEIN E. Thromboplastic activity in human blood. J Appl Physiol. 1952 May;4(11):840–847. doi: 10.1152/jappl.1952.4.11.840. [DOI] [PubMed] [Google Scholar]
  14. RAPAPORT S. I., AAS K., OWREN P. A. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest. 1955 Jan;34(1):9–19. doi: 10.1172/JCI103067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. RATNOFF O. D., CONLEY C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull Johns Hopkins Hosp. 1951 Sep;89(3):245–254. [PubMed] [Google Scholar]
  17. ROSENTHAL R. L. Properties of plasma thromboplastin antecedent (PTA) in relation to blood coagulation. J Lab Clin Med. 1955 Jan;45(1):123–129. [PubMed] [Google Scholar]
  18. SPAET T. H., AGGELER P. M., KINSELL B. G. A possible fourth plasma thromboplastin component. J Clin Invest. 1954 Aug;33(8):1095–1102. doi: 10.1172/JCI102982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. STEFANINI M. New one-stage procedures for the quantitative determination of prothrombin and labile factor. Am J Clin Pathol. 1950 Mar;20(3):233–240. doi: 10.1093/ajcp/20.3.233. [DOI] [PubMed] [Google Scholar]
  20. STERN I., SHAPIRO B. A rapid and simple method for the determination of esterified fatty acids and for total fatty acids in blood. J Clin Pathol. 1953 May;6(2):158–160. doi: 10.1136/jcp.6.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES